Necrotizing Pancreatitis

Definition and Classification (Revised Atlanta 2012)

CT Appearances of the Four Peripancreatic Collections

Pathophysiology

1. Local injury: Autodigestion of pancreatic parenchyma and peripancreatic fat, releasing lipase that causes fat necrosis and calcium saponification (contributing to hypocalcemia in ~25% of patients).
2. Systemic inflammatory response syndrome (SIRS): Release of TNF-α, IL-1, IL-6. Capillary leakage drives intravascular volume depletion.
3. Hemoconcentration: Elevated hematocrit >44% and rising BUN are early markers of severity and predictors of necrosis.
4. Organ failure: Respiratory failure (ARDS, PaO₂ <60 mmHg), renal failure (creatinine >2.0 mg/dL), and cardiovascular collapse can occur in the first 48 hours (early phase), driven by SIRS rather than infection.
5. Late phase (>2 weeks): Dominated by septic complications from infected necrosis; bacteria reach the necrotic tissue primarily via bacterial translocation from the gut.

Clinical Presentation and Diagnosis

1. Typical epigastric pain radiating to the back
2. Serum lipase or amylase ≥3× upper limit of normal
3. Confirmatory imaging on CT/MRI

• WBC 15,000-20,000/μL
• Hematocrit >44% (hemoconcentration)
• BUN >25 mg/dL on admission (strong mortality predictor; BUN AUC 0.918 in PROST trial)
• Hyperglycemia (decreased insulin + increased glucagon + glucocorticoid release)
• Hypocalcemia (~25%)
• Hyperbilirubinemia (~10%)
• ALT >3× ULN strongly suggests gallstone etiology

• Ultrasound: First-line; evaluates gallstones and CBD dilation but poor for necrosis
• Contrast-enhanced CT (CECT): Gold standard for necrotizing pancreatitis. Non-enhancing pancreatic parenchyma on CECT confirms necrosis. Optimal timing is 72-96 hours after onset (to allow demarcation). Gas within the collection = emphysematous/infected necrosis.
• MRI: Better differentiates solid necrotic debris from fluid (important for drainage planning)

Severity Scoring

• BUN >25 mg/dL
• Impaired mental status (GCS <15)
• SIRS present
• Age >60 years
• Pleural effusion on imaging

Management

1. Resuscitation and ICU Care

• Aggressive IV fluid resuscitation: Balanced crystalloid (Lactated Ringer's preferred over normal saline). Target: falling hematocrit and BUN over first 12-24 hours, urine output >0.5 mL/kg/hr.
• ICU admission: Patients with persistent SIRS at 24 hours, elevated BISAP ≥3, organ failure, or inadequate response to initial resuscitation.
• Analgesia, bowel rest initially, then early enteral nutrition (nasojejunal feeding preferred - reduces infectious complications, maintains gut barrier integrity).

2. Nutrition

3. Antibiotics

• Prophylactic antibiotics are NOT recommended - multiple well-designed RCTs show they do not reduce infectious complications, need for surgery, or death. Overuse drives fungal infections and resistant organisms.
• Therapeutic antibiotics ARE indicated for confirmed or strongly suspected infected necrosis. Agents that penetrate pancreatic necrosis include carbapenems, fluoroquinolones, and metronidazole.
• CT-guided fine-needle aspiration (FNA) with Gram stain and culture is used to confirm infection when clinical status is unclear (sensitivity/specificity mid-90% range). Not recommended routinely due to false-negative risk and theoretical risk of introducing infection.

4. Biliary Etiology

• Cholangitis + biliary obstruction: ERCP within 24-48 hours.
• Gallstone pancreatitis without cholangitis: Early ERCP has no benefit (stone usually passes spontaneously). Cholecystectomy during the same admission in mild disease; delayed in severe disease after recovery.

5. Management of Infected/Symptomatic Necrosis - The "Step-Up" Approach

• First-line for infected necrosis or ANC with clinical deterioration
• Image-guided by interventional radiology (IR)
• Retroperitoneal access preferred to allow potential VARD
• Serial catheter upsizing + intracatheter irrigation with saline/H₂O₂
• Best for collections extending to retroperitoneum or paracolic gutters
• Up to 50% of patients managed with PD alone, avoiding necrosectomy
• Risk: pancreaticocutaneous fistula if communicating with pancreatic duct

• Best for mature WON within 2 cm of stomach or duodenum
• Requires ≥4 weeks from onset for wall maturation
• EUS-guided cystgastrostomy → balloon dilation → pigtail stents or lumen-apposing metal stents (LAMS)
• Direct endoscopic necrosectomy (DEN): endoscope inserted into collection, mechanical debridement
• PENGUIN trial (Dutch Acute Pancreatitis Study Group): endoscopic necrosectomy vs. surgical necrosectomy - significantly fewer major complications/death, fewer pancreatic fistulas, less new organ failure
• Up to two-thirds of patients avoid operative debridement with endoscopic necrosectomy

• If percutaneous drainage fails but complete surgical necrosectomy not needed
• The PANTER trial: step-up approach (PD → VARD) vs. primary open surgical necrosectomy - step-up had significantly fewer complications and less new-onset organ failure

• Reserved for failure of all minimally invasive approaches
• Indications per Maingot's Abdominal Operations:
  • Diagnostic uncertainty / concurrent intra-abdominal catastrophe
  • Infected necrosis documented by FNA or extraluminal gas on CT
  • Severe sterile necrosis with persistent organ failure (ideally ≥2 weeks from onset)
  • Symptomatic organized pancreatic necrosis ("persistent unwellness")
• Delayed surgery (>4 weeks) significantly better than early surgery - allows demarcation, reduces bleeding risk and collateral organ damage

Complications

Prognosis

• Sterile necrotizing pancreatitis: ~10% mortality
• Infected necrotizing pancreatitis: ~20% mortality (effectively 100% without intervention)
• Patients who survive severe necrotizing pancreatitis are at risk for post-necrotizing chronic pancreatitis, as noted in Harrison's (TIGAR-O classification: "Postnecrotic - severe acute pancreatitis")

2025 IAP/APA Guidelines Update: The International Association of Pancreatology 2025 guidelines (PMID 40651900) represent the most current evidence-based recommendations, covering 96 questions across 18 domains including fluid therapy, nutritional support, conservative and interventional treatment of infected necrotizing pancreatitis, discharge criteria, and prevention of recurrence.